Smith & Nephew announces CARTIHEAL AGILI-C Cartilage Repair Implant results

Smith+Nephew announces encouraging results for its CARTIHEAL AGILI-C Cartilage Repair Implant from a recent multicentre randomised controlled trial treating knee cartilage defects. When compared to the current surgical standard of care, the implant demonstrated: Superior pain relief: Patients treated with the CARTIHEAL AGILI-C Implant reported significantly better knee pain relief, and quality of life improvements over a 4-year period. Superior functional gains: Patients treated with the CARTIHEAL Implant reported superior improvements in performing activities related to daily living, sport and recreation at 2 and 4 years. Different patient profiles – same great results: The scaffold effectively treated a broad group of patients across age, lesion size, and presence of osteoarthritis while delivering clinically meaningful results. Smith+Nephew’s FDA-approved CARTIHEAL Implant, which previously received breakthrough designation, is revolutionizing the cartilage repair landscape. In line with AANA’s mission to improve patient outcomes through education and innovation, the implant’s broad indication allows physicians to treat patients who previously may not have had access.